<?xml version="1.0" encoding="UTF-8" standalone="no"?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0"><channel><title>Pharmaguideline</title><description>Pharmaguideline provides all pharmaceutical regulatory guidelines including quality control, quality assurance, microbiology, and production departments. Get all SOPs of these all departments. Calibration and operating procedures of all quality control instruments and operating procedures of all production equipment are also provided on the website. All GMP topics are also covered for quality assurance.</description><managingEditor>noreply@blogger.com (Dr. Ankur Choudhary)</managingEditor><pubDate>Thu, 23 Jul 2026 23:44:08 +0530</pubDate><generator>Blogger http://www.blogger.com</generator><openSearch:totalResults xmlns:openSearch="http://a9.com/-/spec/opensearchrss/1.0/">2331</openSearch:totalResults><openSearch:startIndex xmlns:openSearch="http://a9.com/-/spec/opensearchrss/1.0/">1</openSearch:startIndex><openSearch:itemsPerPage xmlns:openSearch="http://a9.com/-/spec/opensearchrss/1.0/">30</openSearch:itemsPerPage><link>https://www.pharmaguideline.com/</link><language>en-us</language><itunes:explicit>no</itunes:explicit><itunes:subtitle>Pharmaguideline provides all pharmaceutical regulatory guidelines including quality control, quality assurance, microbiology, and production departments. Get all SOPs of these all departments. Calibration and operating procedures of all quality control in</itunes:subtitle><itunes:owner><itunes:email>noreply@blogger.com</itunes:email></itunes:owner><xhtml:meta content="noindex" name="robots" xmlns:xhtml="http://www.w3.org/1999/xhtml"/><item><title>Steps to Calculate MACO for Cleaning Validation in Pharmaceuticals</title><link>https://www.pharmaguideline.com/2026/07/steps-to-calculate-maco-for-cleaning-validation.html</link><category>Cleaning Validation</category><category>Quality Control</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Thu, 23 Jul 2026 21:48:53 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-225351406926619773</guid><description>Cleaning validation is one of the most studied and analyzed processes during the pharmaceutical inspections since it demonstrates that the cleaning of production equipment can be performed with high quality and with full assurance that there would be no cross-contamination. While visual inspection of surface cleanliness is crucial, authorities also require companies to define the maximum </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgKWgIVHaft5-BIVLOZmaRXd8yhvUoI-pH5C79WKHsIJpbUrehcE-7xNv7Vdzy7R-GgmOwKdi2y6MzEtS47_9UoEf7WKuTfLOOon2nkSCPhtINVUe-Z7qbfFTSmt66iUzCshuzWEQBSAuWRV7DkwGGBtMOLjg2ZvXWI6g5BVndO-Pbe31B5ehV1R43cD2Fa/s72-c/maco-calculation.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Worst-Case Product Selection Using Risk Assessment in Validation</title><link>https://www.pharmaguideline.com/2026/07/worst-case-product-selection-using-risk-assessment-in-validation.html</link><category>Cleaning Validation</category><category>GMP</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Mon, 20 Jul 2026 17:36:39 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-2792699715458630166</guid><description>Verification tools are always limited although many pharmaceutical manufacturing sites manufacture various products utilizing the same machines. It is neither sensible nor scientifically acceptable to validate each product separately. In its place, authorities want manufacturers to select typical worst-case products through a documented risk analysis process. If the validation proves that </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgKzLP6SMOAxxcmNvVmCsmq4EdBHPjUGoHyZJrXE9HbTQD5mYQfn5BG-yF61DdjbXYUu38d7sRu7pwT6jftukKYkvqoyn50a_qqCZ9MBezMRhqcm_Mj56S0IS1oMs4gDIJPfdSFwI2rIT4soa1jkzLjW3voI6_j7vP2EIsPQeIMtgg5VEHpihT9_UpvP9wW/s72-c/worst-case-detection-1.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>How to Perform a Mock Audit to Simulate a Regulatory Inspection</title><link>https://www.pharmaguideline.com/2026/07/how-to-perform-mock-audit-to-simulate-audit.html</link><category>Audit</category><category>Quality Assurance</category><category>Regulatory</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Fri, 17 Jul 2026 22:25:44 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-7330580546018396314</guid><description>Each pharmaceutical producer hopes to successfully emerge from a regulatory inspection, which is not possible just because it wishes to do so. Food and Drug Administration (FDA) inspections, as well as other regulators like MHRA, EMA, WHO are scheduled as surprise or unnotified inspections, which quickly spot shortcomings missed by normal internal audits. The difference between a successful </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiOkHuDUhatBWhx-cvkjjYw3m0iU6St4P6KaLLhm3_wUobD1NxKZrmk47OnWC5T3qU3wIqfYIeWH7Ew8bKUE__-2AK7m5DKVAggmwmHOngLbXCwaydsVYQa-AKuIwPyOiu5MkEMrLrQYRSHz026_ygX-Lpez-DNPxKISh1YYos-XeajcYzfW5GUXnRiYwMF/s72-c/mock-audit.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>How to Calculate Sampling Size of Raw Materials | n, p and r Plans</title><link>https://www.pharmaguideline.com/2026/07/how-to-calculate-sampling-size-of-raw-materials.html</link><category>GMP</category><category>Quality Assurance</category><category>Stores</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Wed, 15 Jul 2026 20:27:38 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-6999076738787957944</guid><description>When raw materials are delivered to a manufacturing plant, they pose a threat to the quality of finished goods. The quality department cannot presume that every box, even though it comes from a certified supplier, is uniform and pure. This is why sampling plays such a crucial part in GMP compliance. One of the most common questions I get asked in my internal GMP training is how many containers </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgPSPWhlhN4vI8WQXihhRGbprqAPwhkdqKdsMpKUiIIYAvP8BFFEpn4K117VyHgdToTIQQP0Fe-VkCm8GEzxrmuyHVWghchR2N_VdlSsGggxz66NTn80-jrRraKeJhxEnfbE8H41SDTZK95JenGkCN5ttq0tYEZQ2AGDgt64cmg49W8YPE_oMdFjluz5WcN/s72-c/raw-material-sampling.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Eliminating Dead Legs in Pharmaceutical Piping Systems</title><link>https://www.pharmaguideline.com/2026/07/eliminating-dead-legs-in-piping-systems.html</link><category>Engineering</category><category>GMP</category><category>Water</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Mon, 13 Jul 2026 20:20:18 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-8984492405570895266</guid><description>The piping systems and water systems are made to carry vital services like PW, WFI, pure steam, process gases and CIP solutions without compromising product quality or microbial safety. However, even the most efficient water systems can present a risk of contamination when stagnant regions inside the piping system appear. The presence of dead legs is one of the main culprits responsible for </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhVPwoELBZYPYKk6wolExLPWxbc4qFCmeW0WS4K-LEcaBOMhzRROyvFwKdjV5hajsMDW29V_IwH3iKkmu3nl_IsJlx7ljVN5cT8NgEyIAsQAfeQvSinW6GNAH1DXz1Xr2towNPBaJPlyMKizBU23kgmNkhl_BUV9w8ng3V9sLZIQMcMjnQFWGiywAabtrPG/s72-c/dead-leg.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Validation of Dissolution Methods in Pharmaceutical Analysis</title><link>https://www.pharmaguideline.com/2026/07/validation-of-dissolution-methods.html</link><category>Quality Control</category><category>Test</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Sun, 12 Jul 2026 19:53:17 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-2387604828974757268</guid><description>Dissolution testing is recognized as one of the primary quality control tests for solid dosage forms. It shows how quickly and how much of the active ingredient (API) can be released from the tablets or capsules in the specified dissolving media. As a result, since the dissolution characteristics have a direct impact on drug release and thus bioavailability, the importance of this test is </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgBvRZyOfmEkUYGRlYi1gZWJoFwanJCTch7rMdIZrcFZF8DzJpi7Ng8vBQA8QrX14n1EFHvpiZQx4sIUiCRn1QyDpeK18SUcqhPJgIehvTyR2HSlSg2MIKzb83AMCsZAI0Kt-9n86rRjYbMQswAhJnhe_ogGPSL0sqAshPex0SV_lytEAf7AYhH0qPK9G06/s72-c/dissolution-validation.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Validation Policy in Pharmaceuticals | Purpose, Scope and Benefits</title><link>https://www.pharmaguideline.com/2026/07/validation-policy-in-pharmaceutical.html</link><category>GDP</category><category>Regulatory</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Fri, 10 Jul 2026 20:58:04 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-825790381983240695</guid><description>Validation is one of the main aspects of pharmaceutical quality assurance. It establishes documented proof that facilities, utilities, equipment, processes, cleaning procedures, analytical methods and computerized systems operate in the required way. Validation policies prescribe how the validation process will be managed in the facility while validation reports are applicable to particular </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjrWoW48T0uOSwDfQY-5hhpeaPOuGAGRR6Txl5bIEFDlYR0anpyDv-3f0gRUtdWlGpT4-NcsevqpWKsQldgvzhxv66dXWn0jyz6MElCEO-Ov22vC2ADFqjvCPrapg6vq8Sr-7npwYA2NRKmiwAAEhaaUS-tSC5zM8dV50SY2rWKaSZaBTC9EruYnuWoA-di/s72-c/quality-policy.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Validation of Electronic Logbooks in Pharmaceutical Manufacturing</title><link>https://www.pharmaguideline.com/2026/07/validation-of-electronic-logbooks.html</link><category>Data Integrity</category><category>GDP</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Wed, 8 Jul 2026 22:43:19 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-8047976252909199668</guid><description>Because of the need to enhance efficiency and to minimize data errors and strengthen data integrity, the pharmaceutical sector is currently making the transition from paper-based records to e-systems.  This trend is exemplified by the fact that more and more equipment operation logs, cleaning practices records, calibration logs, maintenance records, environmental and utility operation records are</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhHgMelizWBagRHyQ-fdlDZ5vzhPDVGh1c4G_9fn7EKOokQW6Ween3RxrLulDBXsLufMCb4v6BnjFJU8PyZzH9wH4PDwqtlN1jgR-HKnG640UDXaoYFB5nCfryqOZQnTceT6kthzTBWNI5BkwGxHX5HAbsZhmCLBpmsenG-pgVXVw-iKnMBJHnwMk5e0LQu/s72-c/e-logbooks.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Recovery Factor Studies in Cleaning Validation: A Practical Guide</title><link>https://www.pharmaguideline.com/2026/07/recovery-factor-studies-in-cleaning-validation.html</link><category>Cleaning Validation</category><category>Equipment</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Tue, 7 Jul 2026 12:49:15 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-5130759735098852369</guid><description>Cleaning validation plays a vital role in manufacturing as it ensures that all manufacturing equipment is being cleaned according to the set cleaning limits. Cleaning validation depends on how reliable the chosen analytical method would be as well as how effective the sampling technique used is at getting the residues from the surface of the equipment.One area that is critical to cleaning </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjGVGJM0Ky-Nw__yqqATYxcETfylz4bwrASE3BGUzZ68xxYE1ViilDLIojQI0IQk4BSFkMEYpAnT8gVsKeCe6V00QU5JrGP973_tymdnGgz0SrJjxZrmsutORUqousYRvh8w2jfFMkr7rDszZVFK_9-vrvU6MKFG8JB8U3eN2vMVpUwzD65JYBQtL0v1JDy/s72-c/recovery-factor.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Common Audit Findings in Analytical Method Validation</title><link>https://www.pharmaguideline.com/2026/07/common-audit-findings-in-analytical-method-validation.html</link><category>Quality Control</category><category>Regulatory</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Sun, 5 Jul 2026 14:13:03 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-5172693480762907577</guid><description>Analytical method validation establishes documentation for how an analytical test procedure is adequate for meeting its intended use. When the test will be performed for assays, impurities, dissolution, residual solvents, microbiology, or cleaning validation samples, the reliability of the method will directly impact the quality determination regarding the product. Once a method has been </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiSyNbEZRRQLlQJgQ2-kH4mwg92dZ_LLAmmyfXANkRgKXBo3DgpQgS3BnaeCsN2uFB5SaVZpjhSDezso9J_Se0WdueqoZSe-NxXwHk-EGnMvk7Hf9yeMB0RE7RntLJoOmHMgmVI5nTV9La1QxoqYF6pajaVB1PyfBVtIoUm5q35MsBRIsKXuuX9wIcIFu8W/s72-c/amv-audit-findings.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Water System Validation After Major Maintenance in Pharmaceuticals</title><link>https://www.pharmaguideline.com/2026/07/water-system-validation-after-major-maintenance.html</link><category>Engineering</category><category>Validation</category><category>Water</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Fri, 3 Jul 2026 20:05:02 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-9209348997104600553</guid><description>One of the most important utility systems at any manufacturing site is the pharmaceutical water system. Depending on whether purified water, water for injection (WFI) or Pure Steam is being produced, the pharmaceutical water system will have a significant degree of impact on product quality, cleaning operations, laboratory process and equipment operation. This is due to the fact that </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjZyktayTD5HlAy9Qvc61cUMPVSUR3WBVeCVF104k7HGZGL_14H68tKQoQO9aU1Fw3KbDhUCRRjmxHxTOzVKu9vMBnQD32P8GwURTDR_pxldfwITDtpW670JLaumqybpXYlxhjIzO_KOHyZkX6crSc7dzWwgMs6ZPXwrD6q2uJAiiiXWWsvfjsN_9Vys7rk/s72-c/water-system-revalidation.png" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Smoke Study Mistakes and Solutions in Pharmaceutical Cleanrooms</title><link>https://www.pharmaguideline.com/2026/07/smoke-study-mistakes-and-solutions.html</link><category>Engineering</category><category>HVAC</category><category>Sterile</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Thu, 2 Jul 2026 21:49:34 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-9144732289176027294</guid><description>One of the most essential qualifications performed within sterile pharmaceutical manufacturing facilities is the execution of smoke studies (airflow visualization studies). These prove by visual verification that the airflow produced protects the sterile products during manufacturing, filling and during any aseptic activity.Due to the publication of the EU GMP Annex 1 (2022), there have been many</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjdyfKvnHFNY7d4ISaOf7H26_2c2wmWC1kYWgBkwBQ3CrdTiL51FP79JjgPvuEP0O7PTT8yDM0Hh2nIgqbaeo-oSx7xRBagw3XEFkSmhk5jkXd4rY6c2mXV8I5oHBshLol8mKHwu9lp0edX0arI7c9xTdZHLgM69ctCn2JEQy570soz0CWRMuOf1jNcr3cu/s72-c/smoke-study.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Cleaning Validation Failures and Their Root Causes in Pharmaceuticals</title><link>https://www.pharmaguideline.com/2026/07/cleaning-validation-failures-and-their-root-causes.html</link><category>Cleaning Validation</category><category>Equipment</category><category>Regulatory</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Wed, 1 Jul 2026 20:41:18 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-3454678504794528072</guid><description>Validation of cleaning processes is an essential function in the pharmaceutical industry by providing documented proof that manufacturing equipment can be cleaned consistently to acceptable limits. Properly validating cleaning processes helps to avoid problems like contaminating one product with another product, carrying over active ingredients, having microbes on in-process materials, detergent </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj-vE3a1szfCDV6UZLu5kWEWX2N0rmQLr7N9bWkqlmwPZcSzZWYbPo7J9GlZ3wJCruZIPL7lagV-kyiDYbz65ub9IV7tCrn-L6tTNkccOHnRWnJ_GwZzX_pSfgBd360Z2XTnGHf2L-HjwpmbOoI1bUVVsDcf9T4KpMYw6nd26mquieNp-EqF4Z_qSfyiu2o/s72-c/cv-failure.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Common FDA 483 Observations Related to Process Validation</title><link>https://www.pharmaguideline.com/2026/06/common-fda-483-observations-related-to-process-validation.html</link><category>GMP</category><category>Regulatory</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Tue, 30 Jun 2026 15:50:56 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-5874588743788452235</guid><description>The validation of processes is one of the major cornerstones of manufacturing in the pharmaceutical industry. The process of Validation provides a documented record that demonstrates a manufacturing process is capable of producing products that consistently meet predetermined quality attributes as well as regulatory criteria. Since valid processes can impact product quality, as well as patient's </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj7Qm0xykr171_J1y2KKqBjeSaXLHWeg9BaOMEtCvhUoSL9fVA13Vei7KJTsyh8fp4MYkypokdunBN0bcNckTfs3eFZw43JYfSoB1CTIsYmF690XCw2PGNtgvBZDWleW7PwYcSjV0G2BTf2aX00QWKY-XkUA7FDanYt8dhWZYZMad7luXYjBB587DAoKc5H/s72-w1104-h603-c/process-validation-483s.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Handling Unexpected Validation Results in Pharmaceutical Manufacturing</title><link>https://www.pharmaguideline.com/2026/06/handling-unexpected-validation-results.html</link><category>GDP</category><category>GMP</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Tue, 23 Jun 2026 10:00:00 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-4695294251978307387</guid><description>The purpose of validation activities is to provide evidence that pharmaceutical processes, equipment and utilities, computerized systems and cleaning procedures are consistently functioning as they were intended to consistently. In most cases, validation protocols have a clear definition of the acceptance criteria and expected outcome and provide details based on scientific principles and </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEimpxiSFK29HxzD_AF5QdDpqLgnQWDDjKzzbFxTVrkyZrD2zmSqg5Ja09TiGRwcj72_R2skfrUrCrlsYJSxRHVk4CzTIvSMtCLrTOgHYSKXPi26eRkRGnvOXSaDLWeGdWGbkDU7gSpXfF2_2k2dHj8XflNmWydUiNSto9NS9ArjQ9HC5VMsOUAwVnReYIkk/s72-c/unexpected-results.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>How to Draft an Irresistible Response to an FDA 483 Observation</title><link>https://www.pharmaguideline.com/2026/06/how-to-draft-irresistible-response-to-fda-483.html</link><category>GDP</category><category>GMP</category><category>Regulatory</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Sun, 21 Jun 2026 17:35:58 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-4884120115788655135</guid><description>For any pharmaceutical manufacturer, having an open FDA 483 is one of the more difficult situations to experience. The inspection has concluded; the inspector has issued the objectionable conditions, and it is now up to senior management to convince the agency that the company understands the problems and has the capability of being able to fix those issues.In my experiences, the quality of the </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhP2NaHA-fEMhoXGL7di3RMO9KyFuwhDLtILA1TX-x7whkg4FnOcBscA6eedRxLn87iyWyxMHUQy9f0jpvp4fAp5xSzr0N6x4EJ8IdHAJrghSbO-UH15P80v5pHgGAdtRPFulULPI08r3U4PhIdO6sKWEibIjniiIcQ3fbAZwYWtHQSQtlnXL43PptXzBkG/s72-c/response-to-fda-483.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Risk Assessment in Pharmaceuticals | Principles and Applications</title><link>https://www.pharmaguideline.com/2026/06/risk-assessment-in-pharmaceuticals.html</link><category>GMP</category><category>Quality Assurance</category><category>Regulatory</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Fri, 19 Jun 2026 23:12:25 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-700961040686937903</guid><description>Manufacturing pharmaceuticals entails many processes and systems, equipment and personnel activities that can impact the quality of the product and the safety of the consumer. While there are many strong controls in place and validated systems, it is impossible to completely eliminate all risks. The intent of pharmaceutical quality systems is to not remove every possible risk, but instead </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj1EelrfSU_JNOnWxUdrO7yBJVRUR57WsdUlhl8KY7KmHAelbtpsBLcKx41Yw5EQX89DBKPshlsoL2SPuRExDpPGFAH0kWIlDYMPjzm7RHZaIGzN9LgBRgZMgRJs_p7CL0sfxHVPJxyJPv23borHjwdTHwLzLxdiTMSnMeM24UqlEoO8VEvOqsA-0iBExIt/s72-c/risk-assessment.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>CAPA Effectiveness Evaluation Methods in Pharmaceuticals</title><link>https://www.pharmaguideline.com/2026/06/capa-effectiveness-evaluation-methods.html</link><category>GMP</category><category>Quality Assurance</category><category>Regulatory</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Sat, 13 Jun 2026 14:47:58 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-5035896257305444005</guid><description>The Corrective and Preventive Actions (CAPA) System is a critical aspect of managing the quality of pharmaceuticals. At the same time, CAPA is an important element to assist companies to evaluate deviations, find the root cause(s), corrective actions implemented, and prevent the occurrence of quality issues. However, just because a company implemented a CAPA, that does not mean the CAPA was </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh6zxfuTaVUR3YoRbdi7Q7vDz0BsxP2trPgh4pskPBlrc8rAYKM34HBIISXtXVLmXdxmIudv8nYNSgIL834-p7ilV76dX2RUHjkG69Edf0_X-tuDnumzqpUr8QhJHCbXKpf0Zk_jfcVSV4vQJnmCYLPmGnbGXNh003j9O1Ts6m0_7rFwm_HMAk2sn1Dc54e/s72-c/capa-effectiveness.png" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Working Culture in USFDA Approved Pharmaceutical Plants</title><link>https://www.pharmaguideline.com/2026/06/working-culture-in-usfda-approved-plants.html</link><category>Audit</category><category>GMP</category><category>Regulatory</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Thu, 11 Jun 2026 20:15:24 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-5941043408588447892</guid><description>A USFDA approved pharmaceutical plant is not simply a manufacturing location that has passed an inspection; it is a facility that has quality, compliance and safety built into its daily operations as an organization (as opposed to a facility that uses validated systems, equipment and high tech equipment) to provide best in class products with minimal defects.The difference between a highly </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhCCFHnuiI0oyxLffW-tvRlexCdg2iaZ0-5DvkUsFkmA9bwLsIf7WCiYQhQZWvaAG0KnrPYKQzf_bWKgPkw6Y1GSNy5XoT-UDJaUcV43pQx5M0bs88Ufkc9s1_whjWEK2tYeq6dZskQNzh-Xv6ZZnU21Rl8WfP_qs0lfKlnx1i6eJhWkAIWU7FS1538Ui1c/s72-c/fda-culture.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Validation of Pharmaceutical Utilities | GMP Requirements</title><link>https://www.pharmaguideline.com/2026/06/validation-of-pharmaceutical-utilities.html</link><category>Engineering</category><category>GMP</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Mon, 8 Jun 2026 23:15:37 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-6991283563139867052</guid><description>Utility systems for pharmaceuticals are essential elements for a manufacturing enterprise because they affect product quality and environmental controls. In addition, utilities are also required to operate consistently and reliably under validated conditions to satisfy Good Manufacturing Practices and FDA regulations.From my experience, many manufacturing deviations have been created not by </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhTIfBSN_Y6AjpEnEz1XySDkvc32wYGnuIpADOgEIw5EKf24glOtNcEe7Vp9glu33k4UPZ74dMU3XLKp6gtxmBzNpXvBRLE-z9WVu8iNJdhWDDLy0wxnybxAwhA1-JOAufJcZetyQb33mU-dBuQt06qbk4FxjKqcLIjip7y4ZOpZP_g2H_lQOVbm2FnzW5B/s72-c/utility-validation.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>FDA Forms Generally Used in Pharmaceutical Inspection</title><link>https://www.pharmaguideline.com/2014/11/fda-forms-issued-in-inspections.html</link><category>Audit</category><category>GMP</category><category>Regulatory</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Sat, 6 Jun 2026 23:09:11 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-5884959220224400963</guid><description>Regulatory inspections are a fundamental part of the pharmaceutical manufacturing process. They allow a company to verify compliance with Current Good Manufacturing Practice (cGMP) requirements and any related regulatory requirements. Investigators from the Food and Drug Administration (FDA) document the inspection activities, observations, evidence collected and regulatory actions using various </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgTrdG39mDZ-F-deUbVMaW_qBAU55iXOZ9cRql1u0wrseC3Kfs0Nsi9UXGmRhkEu70wSHgX4fEqVAGaukXA56QyDicxA1iBJsvj9_bheGx4rFV7bN9mZDsgadfPKwoRigfjo6KxvmoYnc8JRb_zZhyvn6IaO7OXLrwHcxwaabko6V1noWKq9UE268jdjlu9/s72-c/fda-forms.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">1</thr:total></item><item><title>GMP Documentation Errors and Solutions in Pharmaceuticals</title><link>https://www.pharmaguideline.com/2026/06/gmp-documentation-errors-and-solutions.html</link><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Thu, 4 Jun 2026 22:41:10 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-2924603561205374189</guid><description>The foundation of quality systems in the manufacturing and distribution of pharmaceuticals is based upon the documentation of work performed. Work that is not documented is deemed not to be done in a regulated environment.Because of this principle, documentation practices play a significant role in determining product quality, whether companies are compliant with the law, the ability to release </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjqnqDr7XieetBplR5CX91I2h12FDCktkgsW5XB9q3knRE8eAl1B1CgKTBk0LW9IMS0hrYSQ9ttf6R5xfiV5KwD-hrq8dTP2nGlFqN1HX6X8u6FVmkmd8Tz-h2O_CJIANe8FN-eGoke-7r5OlYv1BfiIx-j1cL1Es1uIxafi-tOzYwPcEmN_xBA6IS2p1bO/s72-c/doc-error.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Energy Saving Strategies in Pharmaceutical Manufacturing Plants</title><link>https://www.pharmaguideline.com/2026/06/energy-saving-strategies.html</link><category>Engineering</category><category>Equipment</category><category>HVAC</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Wed, 3 Jun 2026 00:16:18 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-5922146625883804674</guid><description>Energy usage is one of the biggest business costs in pharmaceutical manufacturing facilities. Modern pharmaceutical factories have complex facilities that include HVAC systems, purified water, compressed air, cleanrooms, production equipment, cooling and an automated manufacturing line, all of which require large quantities of electricity, gas and fuel.I have often seen pharmaceutical companies </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjv7wuXXTmk983KARu3ybfQ1mqI0ouWgj1k46kGe6cP7H3pkdjqrU-cqPG6tbBUclCO2LUUVgAIvUfiRLIacBk-p4mguzjJJfwHzN_jq3-nacxevCwMs08sG_zJgzu8l7wqpWLFspR_ae5Ycjfm7KWrD_OSzgky4xDGTWr8DYnqMVqF7HXuFK3dRRO2ZD44/s72-c/energy-saving.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Stability Study Failures and Investigations in Pharmaceuticals</title><link>https://www.pharmaguideline.com/2026/05/stability-study-failures-investigation.html</link><category>Quality Control</category><category>Regulatory</category><category>Stability</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Sat, 30 May 2026 23:32:43 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-6934278535464817006</guid><description>Stability studies are extremely important scientific and regulatory functions in the pharmaceutical industry because they define your product's shelf life, recommend appropriate storage conditions, define packaging options and validate your product's quality from the initial stages of development through the final production of the product. When stability studies fail, the consequences can be </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhtdargnR8osP0wcKgFSq-GTpz-VtBr7I0e2gtVe8od_EmeCElUWmdlYv6YOPToaJ6CYr0kQcvylgm1R7m6Zgj8x_gvPkEBrBBJVvZsgVFJH7yplAfQ3K795zI0fUPkyacccoVr8rfbxm81sIR9By6QbWEBeqKW1kYDnwvty5x2wzLDyy0L18n6UZuRNwJn/s72-c/stability-failure.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Fire Safety in Pharmaceutical Plants | GMP and Risk Control</title><link>https://www.pharmaguideline.com/2026/05/fire-safety-in-pharmaceutical-plants.html</link><category>Engineering</category><category>Equipment</category><category>Safety</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Sun, 24 May 2026 22:48:06 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-8458881775265151753</guid><description>Fire safety plays an important role within pharmaceutical manufacturing as many hazards are associated with fires and explosions from solvents, chemicals, dust created during processing, electrical equipment, utility systems and/or high temperatures generated through machinery in order to produce the products. If a fire were to occur in a pharmaceutical facility all of the following could happen:</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiW4KUU2At2Xt9NhFsk53IAZ71BnAl8ZfOQhxKGJuf1FpHeyZyJBsu9vHKn9E3M38y74FxV_o1LYIiJnX3-9XouZY-BQtLR9RcLW1SangILQJrwDeDJYV8i8H5l0al9zVgT8UPHQArtWfWJN5yDVeay0OoF3KgdysKzjuB71kMCyLnTrAq_8uXhvLGxm73d/s72-c/fire-safety.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Principle and Working of Autoclave in Pharmaceuticals</title><link>https://www.pharmaguideline.com/2018/09/principle-and-working-of-autoclave.html</link><category>Equipment</category><category>Microbiology</category><category>Sterilization</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Sat, 23 May 2026 20:48:23 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-980900738152335956</guid><description>Sterilization is an essential operation in pharmaceutical manufacturing, particularly when it comes to sterile products. Impacting directly upon patient safety, contamination control is of utmost importance at sterile product facilities. Within the entire spectrum of methods used to sterilize materials for use in the pharmaceutical industry, autoclaving (steam sterilization) is presently accepted</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhZItAIOdR707YtmKHWLnszMbwATs_KdiHMEklwLu2tp4ed6aBg92wsqEyHcqF8PQsXxprPcwWE4MHj1DzmdPyutS3Jng3SNscQskyAMG-_cMOnQ7QgHf6vzbFrKtkgSZbIhVqOxysDVDpEQRWfdR2c-sgmWf_GATAlax0WqSsDVIs9AdaPXjPHM9ARALZY/s72-c/autoclave.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">1</thr:total></item><item><title>How to Reduce Manufacturing Costs in Pharmaceutical Industry</title><link>https://www.pharmaguideline.com/2026/05/how-to-reduce-manufacturing-costs.html</link><category>Protocol</category><category>Quality Assurance</category><category>Regulatory</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Thu, 21 May 2026 19:14:11 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-8808217686703320543</guid><description>The pharmaceutical market is a heavily regulated, highly competitive environment where a small drop in manufacturing cost can mean the difference between profit and loss, long-term sustainability in business between failure and a lack of survival. Increasing prices of raw materials, compliance regulations, labor, energy and equipment maintenance-related costs continue to wreak havoc on global </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhh9Zo7qu6KO8rIlyLn494Qwk1k65iQlsCis5QGZ6zAl-uCV94TphtdmfnzimsgzyIt7jA1C1EY4i8pfg0wq2M9A2MRhEzL6tLaw1yADCPYKAhGfWklzBAxyAv0vCDc6911H8DDs84kWxapFYqI8dXAeOvi5Ny4o4r7A-04IQjmNaB1qywsUOK86jCriChC/s72-c/production-cost.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Validation of Stability Chambers in Pharmaceuticals | Complete Guide</title><link>https://www.pharmaguideline.com/2026/05/validation-of-stability-chambers.html</link><category>GMP</category><category>Stability</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Mon, 18 May 2026 20:52:02 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-4046037982441015262</guid><description>Stability testing represents one of the most critical components of the pharmaceutical industry as it establishes how long a drug product can continue to be produced in a safe and effective manner once manufactured through appropriate storage conditions (e.g., fresh or dried on a shelf for a particular period of time). Stability studies depend on proper operation of the stability chamber to </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhUp7PnxP3zQ5ze5HHwstMLHUwQYxZIcHGdUkkMK3yoNJsdPAJ6MUEYV-eERrCDlFceM8EdTzUBD0c2v1i6f9F1lk9_65wHbY1vabyOjYWgxdYxFfwGL9omri2M8B56pOub-ixVdaNiG4G5bQ-zppKRfMdTc0En60q85PTCg8gm06BzD7XykS6VhsvbBYGz/s72-c/stability-chamber.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>How to Create a Batch Manufacturing Record (BMR)</title><link>https://www.pharmaguideline.com/2015/05/batch-manufacturing-record-bmr.html</link><category>GMP</category><category>Production</category><category>Quality Assurance</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Sat, 16 May 2026 12:59:59 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-1263105588275870901</guid><description>An essential document for pharmaceutical manufacturing is the Batch Manufacturing Record (BMR). The BMR contains all the details on how to make a specific batch of product and is a record of evidence that will confirm that the batch was manufactured according to approved procedures. An ideal BMR supports the quality, traceability, consistency and regulatory compliance of the product.During an </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgGa7dGGQwBZKde5N39_G5Z0rjAME5ajmTjVem2OMrv9Ac1dGf7HDF2ZZ_IZPSI7mH5pVeOZLO7wAiviGnbBwKYV3uW0VuLmGensUXkyTQ10JM-jKeO0EsOqUfIVOSBOmQdY-kZ6Zi4VixEDe7vXwommVR2buMs76ck4u2_MWIRHodD4CMKMfSamNEsUJY7/s72-c/bmr.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">3</thr:total></item><item><title>Cleaning Validation Challenges in Oral Solid Dosage Manufacturing</title><link>https://www.pharmaguideline.com/2026/05/cleaning-validation-challenges-in-osd-manufacturing.html</link><category>Cleaning Validation</category><category>Equipment</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Thu, 14 May 2026 13:25:37 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-2908420281482110118</guid><description>Cleaning validation is one of the most critical components of pharmaceutical production due to its role in ensuring that all equipment used in manufacturing processes is cleaned according to predetermined criteria. In OSDs, the multiple-product use of equipment makes cleaning validation even more crucial than other forms of pharmaceutical manufacturing since improper cleaning can result in </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiK3phyphenhyphenJgdIx3qckbnXmwWZn-gWsfSvPROnt9Oi6NVtstLCDVpG4zIEGDZkvQi-p6VrFTNk-LwUDUEpDm-sLJn9BEpRU9_MZrO_aQQKa95HnYU_e-ow6fkT7CQpbMyWX9e22JkCb3zfXUDk6PIMYzSgdvP2UYoUBPNdUyRpqACK3KPWAxIYnZneqgDeks2E/s72-c-rw/cv-challenges.png" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item></channel></rss>